U.S. markets close in 4 hours 9 minutes

Medical Marijuana, Inc. (MJNA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0304+0.0004 (+1.33%)
As of 11:35AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0300
Open0.0314
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0300 - 0.0315
52 Week Range0.0100 - 0.2200
Volume1,887,195
Avg. Volume13,044,396
Market Cap104.709M
Beta (5Y Monthly)0.01
PE Ratio (TTM)15.20
EPS (TTM)0.0020
Earnings DateAug 23, 2021 - Aug 27, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • GlobeNewswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Receives Approval to Join Top Two Japanese Hemp Industry Organizations

    SAN DIEGO, July 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has been approved to join two of the leading hemp industry organizations in Japan, Hokkaido Industrial Hemp Association (HIHA) and Association for Japan Cannabinoid

  • GlobeNewswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Releases Broad-Spectrum CBD-Infused Gummies

    MJNA Medical Marijuana, Inc. Subsidiary HempMeds® Releases Broad-Spectrum CBD-Infused Gummies SAN DIEGO, July 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has released a brand new product to complement its extensive product l

  • GlobeNewswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Latin American Operations Achieves Best Revenue Month Ever in June 2021

    SAN DIEGO, CA, July 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Latin American operations of its subsidiary HempMeds® achieved its best revenue month ever in the history of the Company in June 2021. In Latin America, the Company increased its rev